Reckitt Benckiser retains EY to sell its detergent business unit in Spain for EUR 200m
Reckitt Benckiser encargaría a EY la venta de su negocio de detergentes en España por EUR 200m
Intel ID : 362073
|
||||
| Intel ID | 362073 | |||
| Value | EUR 200,00m | |||
| Native Currency | Euro (EUR) | |||
| Date |
 |
|||
| Country | |
|||
| Geography |  |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Primary Subsector (TTRSC) |
15.04.02 Household Products (Primary) 15 Consumer Products & Services / 15.04 Consumer Nondurables |
|||
| Secondary Subsectors (TTRSC) |
15.04.03 Personal Care Products 15 Consumer Products & Services / 15.04 Consumer Nondurables 30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|||
| Type |
|
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
15.04.02 Household Products 15 Consumer Products & Services / 15.04 Consumer Nondurables |
||
| Country |
|
||
| Description |
|
Seller
| Name |
|
|||
| Subsector (Old TTR Sectors) |
|
|||
| Primary Sector (TTRSC) |
15.04.02 Household Products 15 Consumer Products & Services / 15.04 Consumer Nondurables |
|||
| Secondary Sectors (TTRSC) |
15.04.03 Personal Care Products 15 Consumer Products & Services / 15.04 Consumer Nondurables 30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|||
| Country |
|
|||
| Website |
|
|||
| Description |
|
Financial Advisory
| Parties | Advisor | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|
|
|
- |
Radar
| Date | Title | Type | Intel Grade | Country | Subsector | ||
|
|
|
|
|
|
|
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.